FDA improves generic approval rate under Trump: report

The US Food and Drug Administration’s (FDA) generic drug approval rate has increased at a “rapid rate” since January 2017, despite the number of branded drug patent expirations declining during this period.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA’s Gottlieb launches biosimilars action plan

19 July 2018 The US Food and Drug Administration is not going to play regulatory ‘whack-a-mole’ with companies trying to delay or derail the entry of biosimilar competitors, according to Scott Gottlieb, commissioner of the FDA.

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA’s Gottlieb launches biosimilars action plan

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA’s Gottlieb launches biosimilars action plan